Journal list Promote Sponsor
verified SJR 0,981 · Q1 • database Scopus / SJR & Web of Science indexed
European Addiction Research
Switzerland · S. Karger AG
workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

European Addiction Research

European Addiction Research is a journal indexed in SJR in Medicine (miscellaneous) and Health (social science) with an H index of 64. It has an SJR impact factor of 0,981 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,981.

ISSN: 1022-6877
Publisher: S. Karger AG
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,981 Q1
H-index 64
Acceptance rate pie_chart
29% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,981

H-index

64

Docs (year)

48

Docs 3y

145

Total refs

2117

Cites 3y

404

Citable 3y

140

Cites/Doc 2y

2.16

Ref/Doc

44.1

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cannabis Psychosis and Acute Schizophrenia

View more

Withdrawal from Methadone Maintenance Treatment

View more

Criminality in Female Inpatients with Substance Use Disorders

View more

Criminality in Drug Addicts: A Follow-Up Study over 25 Years

View more

Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence

View more

Comparison of Alcohol-Dependent Patients with and without Physiological Dependence

View more

Cognitive-Motor Performance of Methadone-Maintained Patients

View more

Cocaine Use and the Utilisation of Drug Help Services by Consumers of the Open Drug Scene in Hamburg

View more

Co-Ordination and Continuity of Care in Substance Abuse Treatment

View more

Children Attending Addiction Treatment Services in Dublin, 1990-1999

View more

Characteristics of Long-Term Cannabis Users in Sydney, Australia

View more

Changes in Prevalence of Problem Opiate Use in Germany between 1990 and 2000

View more
SHOW MORE ARTICLES

Challenges and Approaches to Estimating Mortality Attributable to the Use of Selected Illicit Drugs

View more

A Comparison of Heroin Chasers with Heroin Injectors in Switzerland1

View more

Buprenorphine Maintenance in Pregnant Opiate Addicts

View more

Average Volume of Alcohol Consumption, Drinking Patterns and Related Burden of Mortality in Young People in Established Market Economies of Europe

View more

Association between the Engagement of Relatives in a Behavioural Group Intervention for Smoking Cessation and Higher Quit Rates at 6-, 12- and 24-Month Follow-Ups

View more

Are the Twelve Steps More Acceptable to Drug Users than to Drinkers?

View more

Applying Principles of Comparative Risk Analysis to Substance Abuse-Related Burden

View more

An Open Study with Acamprosate in Belgium and Luxemburg: Results on Sociodemographics, Supportive Treatment and Outcome

View more

An Evaluation of the Therapeutic Programme Conducted by the Southern Regional Alcohol-Abuse Treatment Centre: Study on the Programme's Results One Year after Discharge from Inpatient Care

View more

Alcohol Use Disorders in French University Hospital Patients

View more

Alcohol Consumption during Methadone Maintenance Treatment

View more

Affective Decision-Making Is Predictive of Three-Month Relapse in Polysubstance-Dependent Alcoholics

View more

FAQs